Gas Mark 8, Ltd.’s Post

Excited to share that Nuffield Health's Cancer Centre London (CCL) is now part of Icon Group and Icon Cancer Centre - United Kingdom.  This acquisition marks the next step in Icon and Nuffield Health’s partnership and will strengthen our services at CCL, opening up further opportunities for our two organisations to deliver the best possible care to more people in the UK. To my colleagues at CCL – welcome to Icon – you are part of an innovative and growing global team committed to the best patient care. Learn more 👇 https://lnkd.in/ekR5p5zN Aldo Rolfo Mark Middleton OAM Claire Smith Kelly Jenner Sarah Blinco Catherine Mercer

#ExcitingNews: The National Cancer Institute (NCI) has awarded $12.45 million to establish ASPIRE, a national cohort to study cancer risks in diverse Asian American communities. This effort addresses the underrepresentation of Asian Americans in clinical trials and aims to uncover unique cancer risk factors. UC Irvine, in partnership with University of California, San Francisco and other institutions, will help recruit 20,000 participants. Dr. Sora Park Tanjasiri and Dr. Sunmin Lee will lead these efforts at UC Irvine Public Health, focusing on reducing the cancer burden on Asian American communities. Read full article: https://lnkd.in/g8nWWHbn #CancerResearch #AsianAmericanHealth #ClinicalTrials #UCISchoolOfMedicine #AANHPI #AsianAmerican

Over the past decade, patient-reported outcomes (PROs) have improved patient-clinician communication and care quality, yet Black women are significantly underrepresented in PRO data collection. To address this, the National Cancer Institute (NCI) funded a 4-year project aimed at increasing #PRO engagement among Black women with #breastcancer. To aid this important project, ACCC helped to identify community cancer centers that serve a high proportion of Black women with breast cancer as partners in this project. The project uses the mobile-friendly "imPROVE" platform to study implementation barriers in 5 community cancer centers across the US. The goal is to refine workflows through the imPROVE platform progressively. By using sequential launches for each site, lessons can be learned and shared throughout the project. Baptist Medical Group (Baptist Memorial Health Care Corporation) University of Maryland Medical Center Luminis Health Boston Medical Center (BMC) NewYork-Presbyterian Hospital This initiative marks the beginning of a journey to enhance cancer care for Black patients through PROs. Read the blog https://bit.ly/4b5prI9. Thank you to authors, Maria Orlando Edelen, PhD and Manraj K., PhD #CancerCare #HealthEquity #PatientReportedOutcomes 

When it comes to cancer, there can't be thoughts about "my team" or "your team." It is critical that we work together to connect with our communities to address disparities. #cancer #cancerawareness #communityengagement #communityoutreach

🌸 At #MELIORA, breast cancer prevention goes beyond numbers—it’s about empowering women to take charge of their health. By harnessing the power of technology, we’re supporting personalized lifestyle changes that have the potential to significantly reduce #BreastCancer risk.     🤝 As part of the MELIORA project, BioAssist contributes to this vital mission, leveraging cutting-edge solutions that make a real difference in women's lives. This October, during #BreastCancerAwareness Month, we continue our efforts to raise awareness and promote healthier life choices for women across Europe.     Let’s work together to create a future where prevention and well-being are priorities for all. 💗    #BreastCancerAwareness #CancerPrevention #DigitalHealth #AI  EUROPA DONNA - The European Breast Cancer Coalition European Institute of Women's Health, CLG ESMO - European Society for Medical Oncology  The Breast Cancer Research Foundation  National Breast Cancer Foundation 

Representation matters in clinical trials. The more diverse a group of clinical trial participants is, the more we can learn about the safety and efficacy of a potential medicine or vaccine for people now and in the future. We partnered with @Touch, The Black Breast Cancer Alliance on When We Tri(al), a movement that is amplifying the voices of Black women impacted by #BreastCancer and fostering more inclusive healthcare research. Through our partnership with TOUCH and our collaboration with the @American Cancer Society to #ChangeTheOdds, we are working to address potential barriers to clinical trial participation and empower historically underrepresented communities to learn about clinical trial opportunities. Join us in working toward more inclusive and diverse healthcare. #ClinicalTrialsAwarenessDay #PFEColleague

Representation matters in clinical trials. The more diverse a group of clinical trial participants is, the more we can learn about the safety and efficacy of a potential medicine or vaccine for people now and in the future. We partnered with @Touch, The Black Breast Cancer Alliance on When We Tri(al), a movement that is amplifying the voices of Black women impacted by #BreastCancer and fostering more inclusive healthcare research. Through our partnership with TOUCH and our collaboration with the @American Cancer Society to #ChangeTheOdds, we are working to address potential barriers to clinical trial participation and empower historically underrepresented communities to learn about clinical trial opportunities. Join us in working toward more inclusive and diverse healthcare. #ClinicalTrialsAwarenessDay #PFEColleague

Representation matters in clinical trials. The more diverse a group of clinical trial participants is, the more we can learn about the safety and efficacy of a potential medicine or vaccine for people now and in the future. We partnered with @Touch, The Black Breast Cancer Alliance on When We Tri(al), a movement that is amplifying the voices of Black women impacted by #BreastCancer and fostering more inclusive healthcare research. Through our partnership with TOUCH and our collaboration with the @American Cancer Society to #ChangeTheOdds, we are working to address potential barriers to clinical trial participation and empower historically underrepresented communities to learn about clinical trial opportunities. Join us in working toward more inclusive and diverse healthcare. #ClinicalTrialsAwarenessDay #PFEColleague

Representation matters in clinical trials. The more diverse a group of clinical trial participants is, the more we can learn about the safety and efficacy of a potential medicine or vaccine for people now and in the future. We partnered with @Touch, The Black Breast Cancer Alliance on When We Tri(al), a movement that is amplifying the voices of Black women impacted by #BreastCancer and fostering more inclusive healthcare research. Through our partnership with TOUCH and our collaboration with the @American Cancer Society to #ChangeTheOdds, we are working to address potential barriers to clinical trial participation and empower historically underrepresented communities to learn about clinical trial opportunities. Join us in working toward more inclusive and diverse healthcare. #ClinicalTrialsAwarenessDay #PFEColleague

Representation matters in clinical trials. The more diverse a group of clinical trial participants is, the more we can learn about the safety and efficacy of a potential medicine or vaccine for people now and in the future. We partnered with @Touch, The Black Breast Cancer Alliance on When We Tri(al), a movement that is amplifying the voices of Black women impacted by #BreastCancer and fostering more inclusive healthcare research. Through our partnership with TOUCH and our collaboration with the @American Cancer Society to #ChangeTheOdds, we are working to address potential barriers to clinical trial participation and empower historically underrepresented communities to learn about clinical trial opportunities. Join us in working toward more inclusive and diverse healthcare. #ClinicalTrialsAwarenessDay #PFEColleague